Stocks
News
ETFs
Economy
Currencies
Press Releases
Articles from Diasome
Diasome to Present Phase 2b Results from OPTI-2 Trial Evaluating HDV-Insulin Lispro in Type 1 Diabetes at ADA 86th Scientific Sessions
Data from randomized, double-blind study in 226 adults to be presented as an oral abstract
By
Diasome
· Via
GlobeNewswire
· May 26, 2026